• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

10/02/2023 16:45

Earum Pharmaceutical - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 10Th February, 2023

Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 10th February, 2023 at the Registered Office of the Company, which commenced at 4:00 P.M. and concluded at 4:30 P.M. has Considered and approved the Unaudited Financial Results along with Limited Review Report for the Quarter and Nine Months ended on 31st December, 2022